Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs)

Bedaquiline (a.k.a., Sirturo) is an anti-microbial agent, which is approved by the FDA for the treatment of multi-drug resistant pulmonary tuberculosis (TB). Bedaquiline is a first-in-class diaryl-quinoline compound, that mechanistically inhibits the bacterial ATP-synthase, and shows potent activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiorillo, Marco, Lamb, Rebecca, Tanowitz, Herbert B., Cappello, Anna Rita, Martinez-Outschoorn, Ubaldo E., Sotgia, Federica, Lisanti, Michael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032685/
https://www.ncbi.nlm.nih.gov/pubmed/27344270
http://dx.doi.org/10.18632/aging.100983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032685/
https://www.ncbi.nlm.nih.gov/pubmed/27344270
http://dx.doi.org/10.18632/aging.100983

Ejemplares similares